You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AVIR Exercise Disclosure
Duncan Barbara Gayle · SEC Form 4 · Filed Jun 23, 2026
Exercise
Calculated transaction value
$0
Duncan Barbara Gayle Director
AVIR
Atea Pharmaceuticals
AVIR
Transaction date
Jun 18, 2026
Public filing date
Jun 23, 2026
Filing lag
Filed 5 days later
AVIR daily price context
Close on/before transaction
$4.36
Jun 18, 2026
First close after public filing
$4.48
Jun 24, 2026
30-day return after filing
+6.03%
Through Jul 23, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 29,600 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-279721
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. AVIR Current | Exercise | Jun 18, 2026 | $0 |
| Atea Pharmaceuticals, Inc. AVIR | Exercise | Jun 18, 2026 | $0 |
| Atea Pharmaceuticals, Inc. AVIR | Award | Jun 18, 2026 | $0 |
| Atea Pharmaceuticals, Inc. AVIR | Award | Jun 18, 2026 | $0 |